In cancer, the expression of TIM-3 on T lymphocytes may promote T cell exhaustion and the expansion of suppressive CD4+FoxP3+ regulatory T cells and CD11b+Gr-1+ myeloid-derived suppressor cells (MDSC) (Han et al., 2013; Sakuishi et al., 2013). Here, HAVCR2 is linked to cancer.